Status:
WITHDRAWN
Vitamin B12 for Carpal Tunnel Syndrome
Lead Sponsor:
Tri-Service General Hospital
Conditions:
Carpal Tunnel Syndrome
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy with involving compression of the median nerve in the carpal tunnel. Rather than other progressive disease, CTS is char...
Detailed Description
After obtaining written informed consent, patients with mild to moderate CTS will been randomized into intervention and control group. Participants in intervention group received one-dose ultrasound-g...
Eligibility Criteria
Inclusion
- Age between 20-80 year-old.
- Diagnosis was confirmed using an electrophysiological study
Exclusion
- Cancer
- Coagulopathy
- Pregnancy
- Inflammation status
- Cervical radiculopathy
- Polyneuropathy, brachial plexopathy
- Thoracic outlet syndrome
- Previously undergone wrist surgery or steroid injection for CTS
Key Trial Info
Start Date :
April 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 8 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03802422
Start Date
April 20 2019
End Date
April 8 2020
Last Update
October 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital
Taipei, Neihu District, Taiwan, 886